5P01AG026276-17 |
2022 |
$162912 |
9356 |
Administration Core |
MORRIS, JOHN |
5P01AG026276-17 |
2022 |
$335999 |
9357 |
Clinical Core |
MORRIS, JOHN |
5P01AG026276-17 |
2022 |
$320530 |
9358 |
Fluid Biomarker Core |
FAGAN, ANNE |
5P01AG026276-17 |
2022 |
$214923 |
9359 |
Data Management and Biostatistics Core |
XIONG, CHENGJIE |
5P01AG026276-17 |
2022 |
$1802874 |
9360 |
Tau Burden and Spatial Spread in Preclinical Alzheimer Disease |
MORRIS, JOHN |
5P01AG026276-17 |
2022 |
$389794 |
9361 |
Plasma and CSF Biomarkers that Predict Risk for Symptomatic Alzheimer Disease |
FAGAN, ANNE |
5P01AG026276-17 |
2022 |
$755146 |
9362 |
Alzheimer Disease Progression, Host Gut Microbiome, and Enteric Dysfunction |
ANCES, BEAU M. |
5P01AG026276-17 |
2022 |
$240391 |
9363 |
Mechanisms and Moderators of the Effects of Physical Activity in Preclinical Alzheimer Disease |
HEAD, DENISE P |
2P01AG026276-16 |
2021 |
$229484 |
9363 |
Mechanisms and Moderators of the Effects of Physical Activity in Preclinical Alzheimer Disease |
HEAD, DENISE P |
2P01AG026276-16 |
2021 |
$162914 |
9356 |
Administration Core |
MORRIS, JOHN |
2P01AG026276-16 |
2021 |
$336001 |
9357 |
Clinical Core |
MORRIS, JOHN |
2P01AG026276-16 |
2021 |
$341319 |
9358 |
Fluid Biomarker Core |
FAGAN, ANNE |
2P01AG026276-16 |
2021 |
$214924 |
9359 |
Data Management and Biostatistics Core |
XIONG, CHENGJIE |
2P01AG026276-16 |
2021 |
$1802876 |
9360 |
Tau Burden and Spatial Spread in Preclinical Alzheimer Disease |
MORRIS, JOHN |
2P01AG026276-16 |
2021 |
$352892 |
9361 |
Plasma and CSF Biomarkers that Predict Risk for Symptomatic Alzheimer Disease |
FAGAN, ANNE |
2P01AG026276-16 |
2021 |
$772543 |
9362 |
Alzheimer Disease Progression, Host Gut Microbiome, and Enteric Dysfunction |
ANCES, BEAU M. |
5P01AG026276-15 |
2020 |
$142659 |
8562 |
Admin-Core-001 |
MORRIS, JOHN |
5P01AG026276-15 |
2020 |
$264600 |
8563 |
Core-001 |
MORRIS, JOHN |
5P01AG026276-15 |
2020 |
$253725 |
8564 |
Core-002 |
MORRIS, JOHN |
5P01AG026276-15 |
2020 |
$163175 |
8565 |
Core-003 |
MORRIS, JOHN |
5P01AG026276-15 |
2020 |
$518398 |
8566 |
Project-001 |
MORRIS, JOHN |
5P01AG026276-15 |
2020 |
$348682 |
8567 |
Project-002 |
MORRIS, JOHN |
5P01AG026276-15 |
2020 |
$377579 |
8568 |
Project-004 |
MORRIS, JOHN |
5P01AG026276-14 |
2019 |
$344510 |
8567 |
Project-002 |
MORRIS, JOHN |
5P01AG026276-14 |
2019 |
$345852 |
8568 |
Project-004 |
MORRIS, JOHN |
3P01AG026276-14S1 |
2019 |
$283073 |
8568 |
Project-004 |
MORRIS, JOHN |
5P01AG026276-14 |
2019 |
$142660 |
8562 |
Admin-Core-001 |
MORRIS, JOHN |
5P01AG026276-14 |
2019 |
$264600 |
8563 |
Core-001 |
MORRIS, JOHN |
5P01AG026276-14 |
2019 |
$260391 |
8564 |
Core-002 |
MORRIS, JOHN |
5P01AG026276-14 |
2019 |
$163175 |
8565 |
Core-003 |
MORRIS, JOHN |
5P01AG026276-14 |
2019 |
$531412 |
8566 |
Project-001 |
MORRIS, JOHN |
5P01AG026276-13 |
2018 |
$142659 |
8562 |
Admin-Core-001 |
MORRIS, JOHN |
5P01AG026276-13 |
2018 |
$264600 |
8563 |
Core-001 |
MORRIS, JOHN |
5P01AG026276-13 |
2018 |
$266927 |
8564 |
Core-002 |
MORRIS, JOHN |
5P01AG026276-13 |
2018 |
$163175 |
8565 |
Core-003 |
MORRIS, JOHN |
5P01AG026276-13 |
2018 |
$530336 |
8566 |
Project-001 |
MORRIS, JOHN |
5P01AG026276-13 |
2018 |
$340458 |
8567 |
Project-002 |
MORRIS, JOHN |
5P01AG026276-13 |
2018 |
$377578 |
8568 |
Project-004 |
MORRIS, JOHN |
5P01AG026276-12 |
2017 |
$529959 |
8566 |
Project-001 |
MORRIS, JOHN |
5P01AG026276-12 |
2017 |
$320836 |
8567 |
Project-002 |
MORRIS, JOHN |
5P01AG026276-12 |
2017 |
$377579 |
8568 |
Project-004 |
MORRIS, JOHN |
5P01AG026276-12 |
2017 |
$142659 |
8562 |
Admin-Core-001 |
MORRIS, JOHN |
5P01AG026276-12 |
2017 |
$2067511 |
None |
ANTECEDENT BIOMARKERS FOR AD: THE ADULT CHILDREN STUDY |
MORRIS, JOHN |
5P01AG026276-12 |
2017 |
$264600 |
8563 |
Core-001 |
MORRIS, JOHN |
5P01AG026276-12 |
2017 |
$268703 |
8564 |
Core-002 |
MORRIS, JOHN |
5P01AG026276-12 |
2017 |
$163175 |
8565 |
Core-003 |
MORRIS, JOHN |
2P01AG026276-11 |
2016 |
$142660 |
8562 |
ADMINISTRATION CORE |
MORRIS, JOHN |
2P01AG026276-11 |
2016 |
$2038685 |
None |
ANTECEDENT BIOMARKERS FOR AD: THE ADULT CHILDREN STUDY |
MORRIS, JOHN |
2P01AG026276-11 |
2016 |
$264601 |
8563 |
CORE-001 |
MORRIS, JOHN |
2P01AG026276-11 |
2016 |
$272703 |
8564 |
CORE-002 |
MORRIS, JOHN |
2P01AG026276-11 |
2016 |
$163174 |
8565 |
CORE-003 |
MORRIS, JOHN |
2P01AG026276-11 |
2016 |
$529937 |
8566 |
PROJECT-001 |
MORRIS, JOHN |
2P01AG026276-11 |
2016 |
$289698 |
8567 |
PROJECT-002 |
MORRIS, JOHN |
2P01AG026276-11 |
2016 |
$375912 |
8568 |
PROJECT-004 |
MORRIS, JOHN |
5P01AG026276-10 |
2015 |
$261169 |
5701 |
CSF BIOMARKERS OF ANTECEDENT AD |
FAGAN, ANNE |
5P01AG026276-10 |
2015 |
$128689 |
5699 |
DATA MANAGEMENT & BIOSTATISTICS |
XIONG, CHENGJIE |
5P01AG026276-10 |
2015 |
$549546 |
5700 |
THE NATURAL HISTORY OF AB ACCUMULATION IN PRECLINICAL AD |
MORRIS, JOHN |
5P01AG026276-10 |
2015 |
$170283 |
5696 |
ADMINISTRATION CORE |
MORRIS, JOHN |
5P01AG026276-10 |
2015 |
$2287585 |
None |
AMYLOID IMAGING IN THE ADULT CHILDREN STUDY |
MORRIS, JOHN |
5P01AG026276-10 |
2015 |
$388958 |
5703 |
ANTECEDENT NEUROIMAGING BIOMARKERS |
BENZINGER, TAMMIE LEE SMITH |
5P01AG026276-10 |
2015 |
$233472 |
5702 |
BEHAVIORAL AND NEURAL MARKERS OF ATTENTIONAL CONTROL: ANTECEDENTS FOR AD |
BALOTA, DAVID A |
5P01AG026276-10 |
2015 |
$292448 |
5698 |
BIOMARKER CORE |
FAGAN, ANNE |
5P01AG026276-10 |
2015 |
$263020 |
5697 |
CLINICAL CORE |
MORRIS, JOHN |
5P01AG026276-09 |
2014 |
$174951 |
5696 |
ADMINISTRATION CORE |
MORRIS, JOHN |
5P01AG026276-09 |
2014 |
$400389 |
5703 |
ANTECEDENT NEUROIMAGING BIOMARKERS |
BENZINGER, TAMMIE LEE SMITH |
5P01AG026276-09 |
2014 |
$240264 |
5702 |
BEHAVIORAL AND NEURAL MARKERS OF ATTENTIONAL CONTROL: ANTECEDENTS FOR AD |
BALOTA, DAVID A |
5P01AG026276-09 |
2014 |
$300890 |
5698 |
BIOMARKER CORE |
FAGAN, ANNE |
5P01AG026276-09 |
2014 |
$270551 |
5697 |
CLINICAL CORE |
MORRIS, JOHN |
5P01AG026276-09 |
2014 |
$268646 |
5701 |
CSF BIOMARKERS OF ANTECEDENT AD |
FAGAN, ANNE |
5P01AG026276-09 |
2014 |
$132069 |
5699 |
DATA MANAGEMENT & BIOSTATISTICS |
XIONG, CHENGJIE |
5P01AG026276-09 |
2014 |
$562356 |
5700 |
THE NATURAL HISTORY OF AB ACCUMULATION IN PRECLINICAL AD |
MORRIS, JOHN |
3P01AG026276-07S1 |
2013 |
$65974 |
None |
THE NATURAL HISTORY OF AB ACCUMULATION IN PRECLINICAL AD |
MORRIS, JOHN |
5P01AG026276-08 |
2013 |
$558432 |
5700 |
THE NATURAL HISTORY OF AB ACCUMULATION IN PRECLINICAL AD |
MORRIS, JOHN |
3P01AG026276-07S1 |
2013 |
$15340 |
None |
ADMINISTRATION CORE |
MORRIS, JOHN |
5P01AG026276-08 |
2013 |
$174575 |
5696 |
ADMINISTRATION CORE |
MORRIS, JOHN |
3P01AG026276-07S1 |
2013 |
$44318 |
None |
ANTECEDENT NEUROIMAGING BIOMARKERS |
BENZINGER, TAMMIE LEE SMITH |
5P01AG026276-08 |
2013 |
$400016 |
5703 |
Antecedent Neuroimaging Biomarkers |
BENZINGER, TAMMIE LEE SMITH |
3P01AG026276-07S1 |
2013 |
$24081 |
None |
BEHAVIORAL AND NEURAL MARKERS OF ATTENTIONAL CONTROL: ANTECEDENTS FOR AD |
BALOTA, DAVID A |
5P01AG026276-08 |
2013 |
$240068 |
5702 |
BEHAVIORAL AND NEURAL MARKERS OF ATTENTIONAL CONTROL: ANTECEDENTS FOR AD |
BALOTA, DAVID A |
3P01AG026276-07S1 |
2013 |
$32107 |
None |
BIOMARKER CORE |
FAGAN, ANNE |
5P01AG026276-08 |
2013 |
$300517 |
5698 |
BIOMARKER CORE |
FAGAN, ANNE |
3P01AG026276-07S1 |
2013 |
$28069 |
None |
CLINICAL CORE |
MORRIS, JOHN |
5P01AG026276-08 |
2013 |
$270181 |
5697 |
CLINICAL CORE |
MORRIS, JOHN |
3P01AG026276-07S1 |
2013 |
$27813 |
None |
CSF BIOMARKERS OF ANTECEDENT AD |
FAGAN, ANNE |
5P01AG026276-08 |
2013 |
$268273 |
5701 |
CSF BIOMARKERS OF ANTECEDENT AD |
FAGAN, ANNE |
3P01AG026276-07S1 |
2013 |
$9632 |
None |
DATA MANAGEMENT & BIOSTATISTICS |
XIONG, CHENGJIE |
5P01AG026276-08 |
2013 |
$131698 |
5699 |
DATA MANAGEMENT & BIOSTATISTICS |
XIONG, CHENGJIE |
5P01AG026276-07 |
2012 |
$208916 |
5701 |
CSF BIOMARKERS OF ANTECEDENT AD |
FAGAN, ANNE |
5P01AG026276-07 |
2012 |
$495561 |
5700 |
THE NATURAL HISTORY OF AB ACCUMULATION IN PRECLINICAL AD |
MORRIS, JOHN |
5P01AG026276-07 |
2012 |
$115219 |
5696 |
ADMINISTRATION CORE |
MORRIS, JOHN |
5P01AG026276-07 |
2012 |
$1857806 |
None |
AMYLOID IMAGING IN THE ADULT CHILDREN STUDY |
MORRIS, JOHN |
5P01AG026276-07 |
2012 |
$332901 |
5703 |
Antecedent Neuroimaging Biomarkers |
BENZINGER, TAMMIE LEE SMITH |
5P01AG026276-07 |
2012 |
$180888 |
5702 |
BEHAVIORAL AND NEURAL MARKERS OF ATTENTIONAL CONTROL: ANTECEDENTS FOR AD |
BALOTA, DAVID A |
5P01AG026276-07 |
2012 |
$241159 |
5698 |
BIOMARKER CORE |
FAGAN, ANNE |
5P01AG026276-07 |
2012 |
$72339 |
5699 |
BIOSTATISTICS AND DATA MANAGEMENT CORE |
XIONG, CHENGJIE |
5P01AG026276-07 |
2012 |
$210823 |
5697 |
CLINICAL CORE |
MORRIS, JOHN |
2P01AG026276-06A1 |
2011 |
$129318 |
5696 |
ADMINISTRATION CORE |
MORRIS, JOHN |
2P01AG026276-06A1 |
2011 |
$367026 |
5703 |
ANTECEDENT NEUROIMAGING BIOMARKERS |
BENZINGER, TAMMIE LEE SMITH |
2P01AG026276-06A1 |
2011 |
$205797 |
5702 |
BEHAVIORAL AND NEURAL MARKERS OF ATTENTIONAL CONTROL: ANTECEDENTS FOR AD |
BALOTA, DAVID A |
2P01AG026276-06A1 |
2011 |
$284472 |
5698 |
BIOMARKER CORE |
FAGAN, ANNE |
2P01AG026276-06A1 |
2011 |
$81190 |
5699 |
BIOSTATISTICS AND DATA MANAGEMENT CORE |
XIONG, CHENGJIE |
2P01AG026276-06A1 |
2011 |
$236620 |
5697 |
CLINICAL CORE |
MORRIS, JOHN |
2P01AG026276-06A1 |
2011 |
$234484 |
5701 |
CSF BIOMARKERS OF ANTECEDENT AD |
FAGAN, ANNE |
2P01AG026276-06A1 |
2011 |
$552292 |
5700 |
THE NATURAL HISTORY OF AB ACCUMULATION IN PRECLINICAL AD |
MORRIS, JOHN |
5P01AG026276-05 |
2009 |
$344390 |
4 |
NEUROANATOMICAL BIOMARKERS OF EARLY AD |
CSERNANSKY, JOHN G |
5P01AG026276-05 |
2009 |
$576146 |
1 |
AMYLOID IMAGING IN THE ADULT CHILDREN STUDY |
MORRIS, JOHN |
5P01AG026276-05 |
2009 |
$85357 |
3 |
ATTENTIONAL PROFILES AS AN EARLY MARKER FOR DAT |
BALOTA, DAVID A |
5P01AG026276-05 |
2009 |
$284079 |
9001 |
CLINICAL CORE |
MORRIS, JOHN |
5P01AG026276-05 |
2009 |
$330899 |
2 |
CSF BIOMARKERS OF ANTECEDENT AD |
FAGAN, ANNE |
3P01AG026276-03S2 |
2008 |
$79728 |
None |
AMYLOID IMAGING IN THE ADULT CHILDREN STUDY |
MORRIS, JOHN |
5P01AG026276-04 |
2008 |
$557242 |
1 |
AMYLOID IMAGING IN THE ADULT CHILDREN STUDY |
MORRIS, JOHN |
5P01AG026276-04 |
2008 |
$82725 |
3 |
ATTENTIONAL PROFILES AS AN EARLY MARKER FOR DAT |
BALOTA, DAVID A |
5P01AG026276-04 |
2008 |
$274750 |
9001 |
CLINICAL CORE |
MORRIS, JOHN |
5P01AG026276-04 |
2008 |
$342353 |
2 |
CSF BIOMARKERS OF ANTECEDENT AD |
FAGAN, ANNE |
5P01AG026276-04 |
2008 |
$333705 |
4 |
NEUROANATOMICAL BIOMARKERS OF EARLY AD |
CSERNANSKY, JOHN G |